Monday, June 01, 2020 1:12:03 PM
He fully said they are not leading the trials in South Korea. So the answer was given they do not know. Because they are not the ones running the trials over there. Nor are they going to press Novotech for answers during a pandemic.
Let's keep things in perspective here. There needs to be some compassion in the way you conduct business regarding COVID. Not ringing down the South Koreans every day "hey did you dose anyone with our drug yet?" - like come on. Management is getting it right and I have full confidence in what they are doing.
Great BioPub. I'm outta here!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM